Prior CEO did not want the CE off yet IMO. Then In Aug 2022 Dr, Mark Kester died.
So they had a likely brain damaged by strokes, Hovis now ex CEO to replace, then Kester died, then it was a punt and likely a who has enough vote shares to pick an interim CEO, while the original problem gets fixed or a new plan is put together... As long as the CE stays on insiders are trapped giving time to build a real business to value the company. The current CEO is not a Bio-tech drug guy, just an interim experienced shell reviver and handler is too old now for this stuff (77?) IMO..
If the share structure is truly under 500K now, I am as happy as pig in mud, even with the CE for now.
Lets give them time to find a replacement for Dr. Mark Kester, and Nasdaq caliber CEO and viable plan, either the NDT platform or it and a second item like a deliverable for the delivery NDT Particle complex...
The Pandemic and a death, and bran damaged (I assume from the strokes ex-ceo) delayed everything.
I bought A $10 stock with an 11% dividend that looked safe, and it is under $2 now with no dividend thanks to the FED, so my shares of NDTP are looking way better right now than many Nasdaq stocks.
I think they need time to replace the people they lost to the Pandemic.
It is Pink Current now for the first time in ages. And if the TA is right, we have a share structure to die for now.
We waited this long, and we are closer than before as far as reporting and Pink current wise.
They do need a working website, they may be the CE hold up, and they may be keeping the website dark, until they have real Nasdaq skilled Bio-tech CEO and Dr. Kester replacement.
